EATG » Hepatitis

Hepatitis

Serum viral load predicts HBV flares in patients who cease therapy

Persistent or severe hepatitis followed virological relapse among patients who discontinued treatment with Baraclude for chronic hepatitis B, according to recently published data. Serum viral load at treatment cessation predicted…

Experts and patients come together on people-centred hepatitis response in the Russian Federation

Awareness is growing in the Russian Federation on the need for a strategy on viral hepatitis. Patients and doctors are pointing to the huge burden of disease and the challenges…

Treatment with DAAs reduces the risk of mortality in the first 18 months after the completion of treatment

For the first time, a large study has demonstrated that treatment with direct-acting antivirals (DAAs) significantly reduces mortality rates among people with hepatitis C virus (HCV) monoinfection. The study –…

Direct-acting antivirals successfully treating hepatitis C, says Public Health England

A new report suggests early detection of the disease is key as treatment with direct-acting antiviral therapy in the initial stages has the best results. Public Health England (PHE) is…

Cocrystal announces Phase 1 results for investigational compound for the treatment of hepatitis C

Cocrystal announces positive data from the successful completion of Phase 1a/1b trial of the non-nucleoside polymerase inhibitor CC-31244 for the treatment of chronic hepatitis C infection ATLANTA, GA and BOTHELL,…

FDA panel supports licensing two-dose hepatitis B vaccine

Heplisav-B, Dynavax Technology's experimental hepatitis B vaccine, was recommended for licensing at a meeting of the US Food and Drug Administration's (FDA's) Vaccines and Related Biological Products Advisory Committee on…

UK hepatitis A outbreak in gay men: shortages of HAV and HBV vaccines escalated to ‘national incident’

In May 2017, Public Health England PHE) published details of an ongoing investigation of an outbreak of hepatitis A (HAV) that had been occurring predominantly in MSM in London and…

ECDC epidemiological update: overview of hepatitis A in EU countries as of 1 August 2017

Since the end of 2016, several EU countries have been reporting an increase of hepatitis A cases, both in the general population and in specific risk groups. The aim of…

Hepatitis C patients in Ireland unable to get drugs due to funding problems

Funding freeze blamed on ‘significantly increased and unpredicted’ number of claims The treatment of hundreds of patients with hepatitis C with potentially lifesaving drugs has been abruptly halted due to…

Georgia’s HCV Elimination Program progressing toward 2020 goal

Since its introduction in April 2015, the nation of Georgia’s HCV Elimination Program has shown the potential to rapidly expand HCV care and treatment services, but achieving its 2020 goal…